The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsDonald S. Silverberg, Adrian Iaina, David S. Sheps et al.|Journal of the American College of Cardiology|2000Cited by 729
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyDonald S. Silverberg, Adrian Iaina, Dov Wexler et al.|Journal of the American College of Cardiology|2001Cited by 645